235 related articles for article (PubMed ID: 17080187)
1. Drug discovery in jeopardy.
Cuatrecasas P
J Clin Invest; 2006 Nov; 116(11):2837-42. PubMed ID: 17080187
[TBL] [Abstract][Full Text] [Related]
2. Are we living in the end of the blockbuster drug era?
Debnath B; Al-Mawsawi LQ; Neamati N
Drug News Perspect; 2010 Dec; 23(10):670-84. PubMed ID: 21180653
[TBL] [Abstract][Full Text] [Related]
3. Lessons from 60 years of pharmaceutical innovation.
Munos B
Nat Rev Drug Discov; 2009 Dec; 8(12):959-68. PubMed ID: 19949401
[TBL] [Abstract][Full Text] [Related]
4. Discovery of veterinary antiparasitic agents in the 21st century: a view from industry.
Woods DJ; Knauer CS
Int J Parasitol; 2010 Aug; 40(10):1177-81. PubMed ID: 20430031
[TBL] [Abstract][Full Text] [Related]
5. The right to a trial: Should dying patients have access to experimental drugs?
Groopman J
New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
[No Abstract] [Full Text] [Related]
6. The antibiotic pipeline--challenges, costs, and values.
Wenzel RP
N Engl J Med; 2004 Aug; 351(6):523-6. PubMed ID: 15295041
[No Abstract] [Full Text] [Related]
7. Bioequivalence: the regulatory career of a pharmaceutical concept.
Carpenter D; Tobbell DA
Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
[TBL] [Abstract][Full Text] [Related]
8. Direct-to-consumer prescription drug advertising: history, regulation, and issues.
Huh J; DeLorme DE; Reid LN; An S
Minn Med; 2010 Mar; 93(3):50-2. PubMed ID: 20429178
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial drug discovery in the 21st century.
Bush K
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():10-7. PubMed ID: 15522035
[TBL] [Abstract][Full Text] [Related]
10. Biopharmaceutical statistics in a pharmaceutical regulated environment: past, present, and future.
Segreti AC; Leung HM; Koch GG; Davis RL; Mohberg NR; Peace KE
J Biopharm Stat; 2001 Nov; 11(4):347-72. PubMed ID: 12018784
[TBL] [Abstract][Full Text] [Related]
11. The story so far in R&D.
Prous JR; Khurdayan VK
Drug News Perspect; 2007; 20(1):7-15. PubMed ID: 17332897
[TBL] [Abstract][Full Text] [Related]
12. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
Zelenay JL
Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
[No Abstract] [Full Text] [Related]
13. Pharmaceutical marketing in a new age. Effective campaigns still need to focus on what customers want.
Rao SK
Mark Health Serv; 2002; 22(1):6-12. PubMed ID: 11881547
[TBL] [Abstract][Full Text] [Related]
14. Implications of pharmacogenomics for drug development.
Kirk RJ; Hung JL; Horner SR; Perez JT
Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009.
Kaitin KI; DiMasi JA
Clin Pharmacol Ther; 2011 Feb; 89(2):183-8. PubMed ID: 21191382
[TBL] [Abstract][Full Text] [Related]
16. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?
Elliott C
New Yorker; 2008 Jan; ():36-41. PubMed ID: 18265451
[No Abstract] [Full Text] [Related]
17. Unapproved drugs in the United States and the Food and Drug Administration.
Nasr A; Lauterio TJ; Davis MW
Adv Ther; 2011 Oct; 28(10):842-56. PubMed ID: 21894470
[TBL] [Abstract][Full Text] [Related]
18. Trends in antimicrobial drug development: implications for the future.
Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
[TBL] [Abstract][Full Text] [Related]
19. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act.
Cooper DE
Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915
[No Abstract] [Full Text] [Related]
20. Antimicrobial drug development--the past, the present, and the future.
Powers JH
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():23-31. PubMed ID: 15522037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
